Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 4169-4183

  Lin, Yue Jin ^a   Liu, Yu Sheng ^a   Yeh, Hsin Hwa ^a   Cheng, Tian Lu ^a   Wang, Li Fang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Amphiphilic copolymers; Cellular uptake; Chondroitin sulfate; Micelles; Poly( caprolactone)

Indexed keywords

CHONDROITIN SULFATE; COPOLYMER; DOXORUBICIN; DRUG CARRIER; LIPO DOX; METHACRYLATED CHONDROITIN SULFATE; POLYCAPROLACTONE; POLYCAPROLACTONE GRAFTED CHONDROITIN SULFATE COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL VIABILITY; CHEMICAL BOND; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; INTERNALIZATION; LUNG NON SMALL CELL CANCER; MICELLIZATION; MOUSE; NONHUMAN; PARTICLE SIZE; PH; SINGLE DRUG DOSE; TUMOR VOLUME; TUMOR XENOGRAFT; ZETA POTENTIAL;

ANIMALS; BODY WEIGHT; CELL LINE, TUMOR; CELL SURVIVAL; CHONDROITIN SULFATES; DOXORUBICIN; DRUG CARRIERS; FEMALE; LUNG NEOPLASMS; MICE; MICE, NUDE; MICELLES; MICROSCOPY, CONFOCAL; NANOPARTICLES; POLYESTERS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 84870334103     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S33602     Document Type: Article

References (30)

1. Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65(3):259-269.
2. Yang YQ, Zheng LS, Guo XD, Qian Y, Zhang LJ. pH-sensitive micelles self-assembled from amphiphilic copolymer brush for delivery of poorly water-soluble drugs. Biomacromolecules. 2010;12(1):116-122.
3. Pourcelle V, Devouge S, Garinot M, Preat V, Marchand-Brynaert J. PCL-PEG-based nanoparticles grafted with GRGDS peptide: preparation and surface analysis by XPS. Biomacromolecules. 2007;8(12): 3977-3983.
4. Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MN. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res. 2007;24(5):899-908.
5. Garinot M, Fievez V, Pourcelle V, etal. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release. 2007;120(3):195-204.
6. Liu ZH, Jiao YP, Wang YF, Zhou CR, Zhang ZY. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deli Rev. 2008;60: 1650-1662.
7. Lemarchand C, Couvreur P, Besnard M, Costantini D, Gref R. Novel polyester-polysaccharide nanoparticles. Pharm Res. 2003;20(8): 1284-1292.
8. Rodrigues JS, Santos-Magalhaes NS, Coelho LC, Couvreur P, Ponchel G, Gref R. Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. J Control Release. 2003;92(1-2):103-112.
9. Lemarchand C, Gref A, Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm. 2004;58(2):327-341.
10. Lemarchand C, Gref R, Lesieur S, etal. Physico-chemical characterization of polysaccharide-coated nanoparticles. J Control Release. 2005; 108(1):97-111.
11. Yadav AK, Mishra P, Jain S, Mishra AK, Agrawal GP. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. J Drug Target. 2008;16(6):464-478.
12. Pitarresi G, Palumbo FS, Albanese A, Fiorica C, Picone P, Giammona G. Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug. J Drug Target. 2010;18(4):264-276.
13. Wildgruber M, Lee H, Chudnovskiy A, etal. Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One. 2009;4(5):e5663.
14. Du YZ, Weng Q, Yuan H, Hu FQ. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano. 2010;4(11):6894-6902.
15. Pipitone VR. Chondroprotection with chondroitin sulfate. Drugs Exp Clin Res. 1991;17(1):3-7.
16. Volpi N. Chondroitin sulfate for the treatment of osteoarthritis. Curr Med Chem Anti Inflamm Anti Allergy Agents. 2005;4(3):221-234.
17. Wang LF, Shen SS, Lu SC. Synthesis and characterization of chondroitin sulfate-methacrylate hydrogels. Carbohy Polym. 2003;52(7): 389-396.
18. Chen AL, Ni HC, Wang LF, Chen JS. Biodegradable amphiphilic copolymers based on poly(epsilon-caprolactone)-graft chondroitin sulfate as drug carriers. Biomacromolecules. 2008;9(9):2447-2457.
19. Wang LF, Ni HC, Lin CC. Chondroitin sulfate-g-poly(varepsilon-caprolactone) co-polymer aggregates as potential targeting drug carriers. J Biomater Sci Polym Ed. September 22, 2011. [Epub ahead of print.]
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
21. Wang LL, Zhang Z, Li Q, etal. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod. 2009;24(3): 562-579.
22. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloid Surf B Biointerfaces. 1999; 19(1-4):3-27.
23. Bodnar M, Hartmann JF, Borbely J. Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles. Biomacromolecules. 2006;7(11):3030-3036.
24. Duan K, Zhang X, Tang X, etal. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin. Colloid Surf B Biointerfaces. 2010;76(2):475-482.
25. Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release. 2004;98(3): 415-426.
26. Breunig M, Bauer S, Goepferich A. Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm. 2008;68(1):112-128.
27. Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm. 2010;7(6):1959-1973.
28. Nishiyama N, Kataoka K. Nanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug function. Adv Polym Sci. 2006;193:67-101.
29. Xiong XB, Ma Z, Lai R, Lavasanifar A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials. 2010;31(4):757-768.
30. Maeda H, Matsumura Y. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv Drug Deliv Rev. 2011; 63(3):129-130.